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related air pollution and lung func-
tion in adolescence assessed with
impulse oscillometryTo the Editor:
Most studies linking air pollution exposure and lung function
have focused on spirometry measurements, a method that mostly
reflects total airway resistance and large airway function, rather
than peripheral airway obstruction.1 It has been reported in animal
studies that small aerosol particles in the size range typical of
traffic-related air pollution are deposited in the peripheral
airways.2 Indices related to peripheral airway function correlate 2016 The Authors. Published by Elsevier, Inc. on behalf of the American Academy of
Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).with health status and asthma symptoms in children and adults.3,4
However, it is unknown whether exposure to traffic-related air
pollution affects peripheral airway function.
We have previously reported associations between exposure to
traffic-related air pollution during the first year of life and lung
function decrements measured by spirometry in children and
adolescents.5 Here, we assessed peripheral airway function in
adolescence using impulse oscillometry (IOS).6 IOS is a noninva-
sive, effort-independent technique to assess airway resistance and
reactance, allowing for discrimination between peripheral and
central airway dysfunction.
Our aim was to test whether long-term traffic-related air
pollution during infancy is associated with IOS indices related
to peripheral obstruction in adolescence.
We used data from BAMSE (Children, Allergy, Milieu,
Stockholm, Epidemiological Survey), a longitudinal prospective
birth cohort of 4089 children recruited between 1994 and 1996 in
Stockholm, Sweden. Information on background characteristics,
respiratory health, and exposure factors was obtained from
repeated questionnaires up to age 16 years.6 The current study
population includes 2415 adolescents with information on air
pollution exposure, confounder variables, and IOS data.
In the present analyses, modeled levels of nitrogen oxides
(NOx) and particulate matter with an aerodynamic diameter of
less than 10 mm (PM10) from road traffic were used in the
exposure assessment. PM10 mainly consists of coarse particles
resulting from road surface erosion, while nitrogen oxides (and
ultrafine particles) are directly emitted in motor vehicle exhaust.
The methodology for calculating individual long-term exposure
to local traffic-related PM10 and NOx has been described
elsewhere.5 In brief, outdoor levels of air pollution at individual
residential and school addresses were calculated using emission
inventories and a mathematical model combining data on road
traffic, meteorological conditions, and topography. The calcula-
tions are based on assumptions of the atmospheric dispersion of
the pollutants. The time-weighted (duration at each address)
average outdoor levels of air pollution concentrations during
the first year of life and 1 year before the 16-year follow-up
were entered as continuous variables in the models.
IOS at the age of 16 years was performed using the Jaeger
MasterScreen-IOS system (Carefusion Technologies, San Diego,
Calif) described in detail elsewhere.6,7 Briefly, pressure
oscillation with frequencies varying between 5 and 35 Hz were
superimposed on tidal breathing, producing recordable
waveforms. Advanced signal processing was then used to extract
the respiratory mechanic components from the recorded
waveforms. The primary outcomes resistance (R) and reactance
(X) were plotted against frequency. Resistance is defined as the
ratio of the pressure drop (in Pascal, Pa) over an airway segment
and the flow (L$s21) through that segment. Reactance is
simplistically described as the amount of recoil generated against
the pressure wave. We used the following IOS variables as our
outcomes: (1) resistance at 5 and 20 Hz (R5 and R20), as indices
of total and proximal airway resistance; (2) the fall in resistance
between R5 and R20 (R5-R20), reflecting peripheral airway
resistance; and (3) the square root of the integrated area of low
frequency reactance (AX0.5), assumed to reflect the reactance of
the peripheral airways, and serving as a confirmatory index to
R5-R20.7
Associations between exposure and IOS data were assessed by
median regression, due to right skewed distribution. Results are
TABLE I. Stratified analyses of NOx and PM10 exposure during the first year of life and IOS measurements at age 16 years
NOx (per 10 mg/m
3)
R5-R20 (Pa$L21$s) AX0.5 (Pa$L21)0.5
Nb* 95% CI P value b* 95% CI P value
All 2.0 0.3 3.6 .02 0.17 0.01 0.34 .04 2415
Females 0.3 22.2 2.7 .82 0.16 20.12 0.44 .26 1239
Males 3.2 1.2 5.2 <.01 0.23 20.01 0.46 .06 1176
Asthma at 16 y
Yes 6.7 0.1 13.3 .05 1.22 0.48 1.97 <.01 160
No 1.6 20.2 3.5 .07 0.16 20.00 0.33 .06 2199
Sensitized at 16 y
Yes 2.4 20.8 5.6 .14 0.20 20.01 0.41 .07 1094
No 1.2 21.3 3.7 .35 0.16 20.03 0.35 .10 1267
PM10 (per 5 mg/m
3)
R5-R20 (Pa$L21$s) AX0.5 (Pa$L21)0.5
Nb* 95% CI P value b* 95% CI P value
All 3.0 22.1 8.0 .25 0.40 20.08 0.89 .10 2415
Females 21.8 29.1 5.5 .63 0.24 20.62 1.11 .58 1239
Males 4.9 20.4 10.2 .07 0.43 20.19 1.05 .17 1176
Asthma at 16 y
Yes 24.2 20.6 49.0 .06 3.86 1.40 6.31 <.01 160
No 3.4 21.6 8.3 .18 0.36 20.12 0.83 .14 2199
Sensitized at 16 y
Yes 4.7 24.2 13.6 .30 0.32 20.28 0.91 .29 1094
No 1.8 25.0 8.6 .60 0.50 20.11 1.10 .11 1267
*Beta defined as change in R5-R20 or AX0.5 per 10 mg/m3 of NOx or per 5 mg/m
3 of PM10. Calculated by median regression, adjusted for sex, age, height, weight at 16 years as
well as municipality at birth.
Defined as at least 4 episodes of wheeze in the last 12 months or at least 1 episode in combination with prescription of inhaled corticosteroids.
Defined as IgE values for Phadiatop (airborne allergens) and/or food-mix/Fx5 (food allergens) >_0.35 kU/L (Thermo Fischer Scientific, Uppsala, Sweden).
75 1 1.25 1.5 1.75 2 2.25 2.5 2.75 3
Odds ratio for R5-R20 or AX0.5 >95th percentile (>P95)
(95% Confidence Interval)
>P95:R5-R20
>P95:AX0.5
= NOx (per 10 μg/m³)
= PM10 (per 5 μg/m³)
.
FIG 1. Odds ratio for the association between first year of life exposure to
traffic-related air pollution and above vs below the estimated 95th
percentile of R5-R20 or AX0.5 at age 16 years. Calculated by logistic
regression and adjusted for municipality at birth. 95th percentile based
on quantile regression within the BAMSE (Children, Allergy, Milieu, Stock-
holm, Epidemiological Survey) population using age, height, and weight as
explanatory variables for males and females separately.
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the unit (Pa$L21)0.5 per 10 mg/m3 for NOx and per 5 mg/m
3 for
PM10. Quantile regression was performed to estimate the 95th
percentiles of each IOS index specific to age, height, and
weight in males and females separately (for details, see
the Methods section in this article’s Online Repository at
www.jacionline.org). Logistic regression between air pollution
exposure during the first year of life and lung function was
performed with the outcome dichotomized as above versus
below the estimated 95th percentiles for R5-R20 and AX0.5.
Analyses were performed with Stata 11 (StataCorp LP, College
Station, Tex).
A 10 mg/m3 increase in exposure to traffic-NOx in the first year
of life was associated with a significant increase of 2.0 Pa$L21$s
in R5-R20 (95% CI, 0.3-3.6, P 5 .02) and of 0.17 (Pa$L21)0.5 in
AX0.5 (95% CI, 0.01-0.34; P 5 .04) (Table I). Adjustment for
subsequent exposure time windows, short-term exposures, or
moving anytime during follow-up did not change the
results (see Table E1 in this article’s Online Repository at
www.jacionline.org). No associations were seen for either R5 or
R20 on their own, or from exposure during year 15 to 16 (see
Table E2 in this article’s Online Repository at www.jacionline.
org). Further analyses of first year of life exposure to traffic-
NOx suggested stronger associations in boys and in subjects
with asthma at 16 years, but not in thosewith allergic sensitization
at 16 years (Table I). The effect modification in R5-R20 analyses
was significant for asthma (P5.04 for interaction), but not for sex
(P5 .56). The results for PM10 were in linewith those of NOx, but
not statistically significant. To determine whether exposure to air
pollution was associated with a more severe peripheral airway
obstruction, we analyzed NOx and PM10 exposure in relation to
the odds of having R5-R20 and AX0.5 above versus below theestimated 95th percentile. Associations were indicated between
exposure to traffic-NOx and traffic-PM10 during the first year of
life and above the 95th percentile of R5-R20 and AX0.5 (Fig 1).
In these analyses, PM10 exposure was most prominently
associated with the IOS indices. Exposure characteristics as
well as lung function and anthropometry data for the present study
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this article’s Online Repository at www.jacionline.org).
Our results indicate that exposure to air pollutants from local
traffic during infancy is associated with peripheral airway indices
in adolescence, particularly in those with asthma. This extends
our previous findings from the spirometry analyses, where we
found a negative association on FEV1 from exposure during
infancy.5 Notably, this was observed primarily in individuals
without asthma.
The observed effects are small in absolute terms and may have
little impact on a healthy individual living in areas with low
pollution levels, but are likely to be relevant in areas with
high pollution levels and for susceptible groups such as
individuals with respiratory diseases. Dose and location of de-
positions in the airway tree depends on the density, shape, size, and
hygroscopy of particles as well as breathing pattern, anatomy, and
reactivity of the airways.8 In experimental settings, it has been
observed that deposition of inhaled ultrafine particles (which is
closely linked to modeled NOx) is increased in those with asthma,
relative to healthy subjects.9 This could be a potential mechanism
underlying the stronger association between air pollution and
peripheral airway function observed in individuals with asthma,
compared with previous results on FEV1, where the association
was strongest in individuals without asthma.5
We analyzed both NOx and PM10 as markers of traffic air
pollutants and it should be recognized that these pollutants are
highly correlated and that this study cannot elucidate in detail
which component or mixture of traffic-related air pollution
negatively influences the airways.
In conclusion, our study contributes new knowledge about the
negative effects of exposure to traffic-related air pollutants during
infancy on airway resistance and reactance in adolescence. In
particular, our results suggest that the peripheral conducting
airways are affected by traffic-related air pollutants.
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http://dx.doi.org/10.1016/j.jaci.2016.04.014Club cell secretory protein in
serum and bronchoalveolar lavage
of patients with asthmaTo the Editor:
Club cell secretory protein (CC16) is a homodimeric pneumo-
protein that is mainly produced by nonciliated bronchial
epithelial cells1,2 and is found both in the airways and in the
circulation. The biological functions of CC16 have not been
conclusively determined, but in vitro, ex vivo, and animal studies
indicate anti-inflammatory, immunomodulatory, and antitoxicant
properties of this molecule in the lungs.1,2
Clinical studies have reported decreased circulating levels of
CC16 in asthma.3 In a population-based study,4 although serum
CC16 levels were not associated with asthma per se, they
correlated positively with lung function in patients with asthma,
suggesting that CC16 deficits may be related to disease severity.
This scenario is in line with the relation of low circulating
CC16 levels to prevalence and progression of chronic obstructive
pulmonary disease.5
Whether deficits of circulating CC16 in patients with asthma
reflect similar deficits of this protein in the airways remains
controversial because of inconsistent results from previous
studies.6,7 One study reported lower CC16 levels in bronchoal-
veolar lavage (BAL) fluid from 24 patients with asthma compared
with 24 controls.6 In contrast, another study found both patients
with difficult-to-treat (refractory) asthma and patients with
mild-to-moderate asthma to have higher CC16 levels in induced
sputum than controls.7 When BAL samples were analyzed,
subjects with refractory asthma had higher CC16 levels than
did those with mild-to-moderate asthma.
Assessing airway CC16 in asthma is important because it may
provide insights into whether CC16 deficits in serum from
patients with asthma can be explained by reduced airway CC16
METHODS
Calculation of 95th percentiles of oscillometry
indices
Quantile regression was performed to estimate the 95th percentiles of each
IOS index specific to age, height, and weight in males and females separate-
ly.E1 The estimates were obtained from a selected group of ‘‘healthy’’ subjects,
which consisted of nonsmokers, not exposed to maternal smoking in utero or
at baseline, born in gestational week 37 or later, with birth weight above
1500 g, never had a asthma diagnosis (at 1, 2, 4, 8, 12, or 16 years), and did
not require respiratory support at birth. In addition, subjects were excluded
if they had a disease that potentially might influence their lung function.
Before estimating 95th percentiles, we visually inspected the scatterplots of
IOS indexes against the predictors (age, height, andweight). Very few subjects
were older than 18 years and/or more than 100 kg in weight. These outlying
values were removed from the final group, which comprised 642 females
and 577 males.
REFERENCES
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TABLE E1. Exposure to traffic-NOx during the first year of life and R5-R20 measurements at age 16 years, adjusted for subsequent
exposure time windows, short-term exposure (1-7 d), or moved anytime during follow-up period
Model
Change in Pa$L21$s (95% CI) per 10 mg/m3 of traffic-NOx
All Males Females
Main model* 2.0 (0.3 to 3.6) 3.2 (1.2 to 5.2) 0.3 (22.2 to 2.7)
Main model 1 adjustment for:
NOx 1-8 y 1 8-16 y 3.1 (1.2 to 5.1) 4.4 (1.5 to 7.2) 1.5 (21.7 to 4.6)
Rh 1 Temp (1-7 d) 2.1 (0.5 to 3.8) 3.1 (1.1 to 5.2) 0.4 (22.1 to 2.9)
Rh 1 Temp 1 Ozon (1-7 d) 1.9 (0.0 to 3.8) 3.1 (0.7 to 5.5) 20.3 (23.0 to 2.5)
Rh 1 Temp 1 NOx (1-7 d) 1.8 (20.2 to 3.9) 3.1 (0.9 to 5.4) 0.7 (22.6 to 3.9)
Moved anytime 0-16 y 1.8 (0.1 to 3.6) 3.6 (1.6 to 5.5) 20.1 (23.1 to 2.9)
Rh, Relative humidity; Temp, temperature.
*Calculated by median regression, adjusted for sex, age, height, weight at 16 years as well as municipality at birth.
Short-term exposures: 1-week lag preceding lung function measurement, using hourly mean values from roof top monitoring stations (NOx, Rh, and Temp) and a rural station
(ozon).E3
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TABLE E2. Associations of NOx and PM10 exposure during the first year of life and year 15-16 and IOS measurements at age 16 years
Exposure year 0-1 Exposure year 15-16
n b* 95% CI n b* 95% CI
NOx (per 10 mg/m
3)
R5 (Pa$L21$s) 2415 0.2 23.2 to 3.6 2297 20.4 28.4 to 7.5
R20 (Pa$L21$s) 2415 20.5 23.3 to 2.3 2297 1.6 25.7 to 9.0
R5-R20 (Pa$L21$s) 2415 2.0 0.3 to 3.6 2297 20.4 24.4 to 3.7
AX0.5 (Pa$L21)0.5 2415 0.17 0.01 to 0.34 2297 0.12 20.30 to 0.53
PM10 (per 5 mg/m
3)
R5 (Pa$L21$s) 2415 4.3 25.9 to 14.5 2297 4.1 23.3 to 11
R20 (Pa$L21$s) 2415 6.3 22.2 to 14.8 2297 4.9 22.0 to 11.8
R5-R20 (Pa$L21$s) 2415 3.0 22.1 to 8.0 2297 21.5 25.5 to 2.5
AX0.5 (Pa$L21)0.5 2415 0.40 20.08 to 0.89 2297 0.04 20.35 to 0.43
*Change in respective IOS measurement per 10 mg/m3 of NOx or per 5 mg/m
3 of PM10. Calculated by median regression, adjusted for sex, age, height, weight at 16 years as well as
municipality at birth.
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TABLE E3. Distribution of selected exposure characteristics among all children in the cohort (N 5 4089) and the children included in the
present study on air pollution exposure and lung function at 16 years (n 5 2415)
Covariates*
Full cohort
(N 5 4089)
Study population at 16 y
(n 5 2415y)
n % n % 95% CI
Sex: male 2065 50.5 1176 48.7 47.4-50.0
Socioeconomic status of parents
White collar worker 3323 82.7 2013 84.5 83.5-85.4
Heredity
Parents with allergy and/or asthma 1191 29.5 748 31.4 30.2-32.6
Ethnicity
Any parents born outside of Scandinavia 543 16.0 372 16.1 15.3-17.0
Mother smoking during pregnancy or at 2 mo of child 563 13.8 294 12.2 11.4-13.0
Environmental tobacco smoke exposure at 16 y 413 13.6 287 12.6 11.9-13.2
Adolescence smoking at 16 y 373 12.0 298 12.4 11.8-13.1
Asthma at 0-2 y 334 10.9 208 10.0 9.3-10.7
Asthma at 16 y 199 6.4 160 6.8 6.3-7.3
Sensitized at 16 y 1170 45.9 1094 46.3 45.8-46.9
Mean 6 SD Mean 6 SD 95% CI
Birth weight (g) 3530 6 558 3525 6 556 3510-3539
Birth length (cm) 50.2 6 2.6 50.2 6 2.5 50.2-50.2
Gestational age (wk) 39.5 6 1.8 39.5 6 1.8 39.4-39.6
Exposure concentration during year 0-1
NOx (mg/m
3) 20.9 6 16.5 21.6 6 17.0 21.2-22.0
PM10 (mg/m
3) 5.8 6 3.3 5.9 6 3.3 5.8-6.0
CIs constructed by applying finite population correction factor.
*Covariates relate to the first year of child’s life if not otherwise stated.
Data include subjects with data on IOS at 16 years, municipality at birth, sex, age, weight, height at 16-years examination, as well as exposure information for the first year of life.
Data include subjects answering questionnaire or taking IgE measurement at 16 years, corresponding to 3034, 3108, 3115, and 2547 for environmental tobacco smoke, own
smoking, asthma, and sensitization, respectively.
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TABLE E4. Lung function and anthropometry data from the 16-
year examination in the BAMSE cohort and in the subgroup of
subjects with asthma at age 16 years
Variable
Full study population
Individuals with
asthma*
No. Mean 6 SD No. Mean 6 SD
Age (y) 2415 16.7 6 0.4 160 16.7 6 0.3
Length (m) 2415 173.4 6 9.0 160 172.3 6 8.1
Weight (kg) 2415 65.5 6 11.5 160 67.1 6 12.9
IOS No. Median IQR % No. Median IQR %
R5 (Pa$L21$s) 2415 360 110 160 400 123
R20 (Pa$L21$s) 2415 340 90 160 365 93
R5-R20 (Pa$L21$s) 2415 15 50 160 33 73
AX0.5 (Pa$L21)0.5 2415 15 6 160 19 8
>P95: R5-R20 173 7.2 23 14.4
>P95: AX0.5 167 6.9 29 18.1
IQR, Interquartile range.
*Asthma at age 16 years was defined as at least 4 episodes of wheeze in the last
12 months or at least 1 episode in combination with prescription of inhaled
corticosteroids.E2
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